Phosphorylation and desensitization of the human beta 1-adrenergic receptor. Involvement of G protein-coupled receptor kinases and cAMP-dependent protein kinase.

Persistent stimulation of the beta 1-adrenergic receptor (beta 1AR) engenders, within minutes, diminished responsiveness of the beta 1 AR/adenylyl cyclase signal transduction system. This desensitization remains incompletely defined mechanistically, however. We therefore tested the hypothesis that agonist-induced desensitization of the beta 1AR (like that of the related beta 2AR) involves phosphorylation of the receptor itself, by cAMP-dependent protein kinase (PKA) and the beta-adrenergic receptor kinase (beta ARK1) or other G protein-coupled receptor kinases (GRKs). Both Chinese hamster fibroblast and 293 cells demonstrate receptor-specific desensitization of the beta 1 AR within 3-5 min. Both cell types also express beta ARK1 and the associated inhibitory proteins beta-arrestin-1 and beta-arrestin-2, as assessed by immunoblotting. Agonist-induced beta 1AR desensitization in 293 cells correlates with a 2 +/- 0.3-fold increase in phosphorylation of the beta 1AR, determined by immunoprecipitation of the beta 1AR from cells metabolically labeled with 32P(i). This agonist-induced beta 1AR phosphorylation derives approximately equally from PKA and GRK activity, as judged by intact cell studies with kinase inhibitors or dominant negative beta ARK1 (K220R) mutant overexpression. Desensitization, likewise, is reduced by only approximately 50% when PKA is inhibited in the intact cells. Overexpression of rhodopsin kinase, beta ARK1, beta ARK2, or GRK5 significantly increases agonist-induced beta 1AR phosphorylation and concomitantly decreases agonist-stimulated cellular cAMP production (p < 0.05). Furthermore, purified beta ARK1, beta ARK2, and GRK5 all demonstrate agonist-dependent phosphorylation of the beta 1AR. Consistent with a GRK mechanism, receptor-specific desensitization of the beta 1AR was enhanced by overexpression of beta-arrestin-1 and -2 in transfected 293 cells. We conclude that rapid agonist-induced desensitization of the beta 1AR involves phosphorylation of the receptor by both PKA and at least beta ARK1 in intact cells. Like the beta 2AR, the beta 1AR appears to bind either beta-arrestin-1 or beta-arrestin-2 and to react with rhodopsin kinase, beta ARK1, beta ARK2, and GRK5.

[1]  R. Lefkowitz,et al.  Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. , 1995, Science.

[2]  P. Fishman,et al.  Differences in desensitization between human β1- and β2-adrenergic receptors stably expressed in transfected hamster cells , 1995 .

[3]  C. Malbon,et al.  Oligodeoxynucleotides antisense to mRNA encoding protein kinase A, protein kinase C, and beta-adrenergic receptor kinase reveal distinctive cell-type-specific roles in agonist-induced desensitization. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[4]  S. Green,et al.  A proline-rich region of the third intracellular loop imparts phenotypic beta 1-versus beta 2-adrenergic receptor coupling and sequestration. , 1994, The Journal of biological chemistry.

[5]  J. Benovic,et al.  A beta-adrenergic receptor kinase dominant negative mutant attenuates desensitization of the beta 2-adrenergic receptor. , 1994, The Journal of biological chemistry.

[6]  M. Caron,et al.  An approach to the study of G-protein-coupled receptor kinases: an in vitro-purified membrane assay reveals differential receptor specificity and regulation by G beta gamma subunits. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[7]  R. Lefkowitz,et al.  Identification, purification, and characterization of GRK5, a member of the family of G protein-coupled receptor kinases. , 1994, The Journal of biological chemistry.

[8]  M. Caron,et al.  A highly conserved tyrosine residue in G protein-coupled receptors is required for agonist-mediated beta 2-adrenergic receptor sequestration. , 1994, The Journal of biological chemistry.

[9]  J. Benovic,et al.  Expression, purification, and characterization of the G protein-coupled receptor kinase GRK5. , 1994, The Journal of biological chemistry.

[10]  R. Lefkowitz,et al.  Structure and mechanism of the G protein-coupled receptor kinases. , 1993, The Journal of biological chemistry.

[11]  L. Birnbaumer,et al.  Efficacy of beta 1-adrenergic receptors is lower than that of beta 2-adrenergic receptors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. Lohse,et al.  Molecular mechanisms of membrane receptor desensitization. , 1993, Biochimica et biophysica acta.

[13]  J. Benovic,et al.  Beta-adrenergic receptor kinase. Agonist-dependent receptor binding promotes kinase activation. , 1993, The Journal of biological chemistry.

[14]  S. Liggett,et al.  Structural basis for receptor subtype-specific regulation revealed by a chimeric beta 3/beta 2-adrenergic receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[15]  M. Böhm,et al.  Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. , 1993, Circulation.

[16]  O. Brodde.  Beta-adrenoceptors in cardiac disease. , 1993, Pharmacology & therapeutics.

[17]  J. Granneman,et al.  Coexisting beta 1- and atypical beta-adrenergic receptors cause redundant increases in cyclic AMP in human neuroblastoma cells. , 1992, Molecular pharmacology.

[18]  T. Dawson,et al.  The G-protein-coupled receptor kinases beta ARK1 and beta ARK2 are widely distributed at synapses in rat brain , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[19]  C. Aoki,et al.  Beta-arrestin2, a novel member of the arrestin/beta-arrestin gene family. , 1992, The Journal of biological chemistry.

[20]  S. Green,et al.  Beta 1- and beta 2-adrenergic receptors display subtype-selective coupling to Gs. , 1992, Molecular pharmacology.

[21]  M. Caron,et al.  Receptor-specific desensitization with purified proteins. Kinase dependence and receptor specificity of beta-arrestin and arrestin in the beta 2-adrenergic receptor and rhodopsin systems. , 1992, The Journal of biological chemistry.

[22]  C M Bloor,et al.  Myocardial,β‐Adrenergic Receptor Expression and Signal Transduction After Chronic Volume‐Overload Hypertrophy and Circulatory Congestion , 1992, Circulation.

[23]  D. O'reilly,et al.  Baculovirus expression vectors: a laboratory manual. , 1992 .

[24]  R. Snyderman,et al.  Receptor class desensitization of leukocyte chemoattractant receptors. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[25]  P. Arner,et al.  In vivo interactions between beta-1 and beta-2 adrenoceptors regulate catecholamine tachyphylaxia in human adipose tissue. , 1991, The Journal of pharmacology and experimental therapeutics.

[26]  M. Caron,et al.  The receptor kinase family: primary structure of rhodopsin kinase reveals similarities to the beta-adrenergic receptor kinase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[27]  M. Caron,et al.  Cloning, expression, and chromosomal localization of beta-adrenergic receptor kinase 2. A new member of the receptor kinase family. , 1991, The Journal of biological chemistry.

[28]  M. Caron,et al.  Comparative rates of desensitization of beta-adrenergic receptors by the beta-adrenergic receptor kinase and the cyclic AMP-dependent protein kinase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[29]  M. Caron,et al.  Role of acidic amino acids in peptide substrates of the beta-adrenergic receptor kinase and rhodopsin kinase. , 1991, Biochemistry.

[30]  P. Fishman,et al.  Desensitization of the human beta 1-adrenergic receptor. Involvement of the cyclic AMP-dependent but not a receptor-specific protein kinase. , 1991, The Journal of biological chemistry.

[31]  R. Young,et al.  Epitope tagging and protein surveillance. , 1991, Methods in enzymology.

[32]  B. Sefton.  Measurement of stoichiometry of protein phosphorylation by biosynthetic labeling. , 1991, Methods in enzymology.

[33]  Y. Salomon.  Cellular responsiveness to hormones and neurotransmitters: conversion of [3H]adenine to [3H]cAMP in cell monolayers, cell suspensions, and tissue slices. , 1991, Methods in enzymology.

[34]  M. Caron,et al.  Molecular cloning and expression of the gene for a human D1 dopamine receptor , 1990, Nature.

[35]  M. Hagiwara,et al.  Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. , 1990, The Journal of biological chemistry.

[36]  M. Caron,et al.  Multiple pathways of rapid beta 2-adrenergic receptor desensitization. Delineation with specific inhibitors. , 1990, The Journal of biological chemistry.

[37]  M. Caron,et al.  Beta-adrenergic receptor kinase: primary structure delineates a multigene family. , 1989, Science.

[38]  M. Caron,et al.  Phosphorylation sites on two domains of the beta 2-adrenergic receptor are involved in distinct pathways of receptor desensitization. , 1989, The Journal of biological chemistry.

[39]  M. Caron,et al.  Inhibition of beta-adrenergic receptor kinase prevents rapid homologous desensitization of beta 2-adrenergic receptors. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[40]  J. Port,et al.  Beta 1- and beta 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium. , 1989, Molecular pharmacology.

[41]  E. Harlow,et al.  Antibodies: A Laboratory Manual , 1988 .

[42]  M. Caron,et al.  Cloning of the cDNA for the human beta 1-adrenergic receptor. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[43]  D. Sibley,et al.  A novel catecholamine-activated adenosine cyclic 3',5'-phosphate independent pathway for beta-adrenergic receptor phosphorylation in wild-type and mutant S49 lymphoma cells: mechanism of homologous desensitization of adenylate cyclase. , 1986, Biochemistry.

[44]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[45]  M. Nassal,et al.  A carbene-generating photoaffinity probe for beta-adrenergic receptors. , 1983, Biochimica et biophysica acta.